This guidance provides recommendations for initial infection control in healthcare settings for patients who may be infected with a novel influenza A virus (i.e., an influenza A virus that has not recently been circulating among humans) associated with severe disease.
- Page last reviewed: April 6, 2017
- Page last updated: April 6, 2017
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs